| Variables | Results: Mean (+/− SD) or %. |
| Mean disease duration (months) | 76.49 (+/− 87.2) |
| Mean diagnostic delay (months) | 38.27 (+/− 78.2) |
| Number of painful joints | 5.6 (+/− 7.9) |
| Number of swollen joints | 5.02 (+/− 5.4) |
| Clinical tenosynovitis (%) | 27.7% |
| Number of night awakening | 0.86 (+/− 1.8) |
| Morning stiffness duration (minutes) | 30.4 (+/− 37.7) |
| Joints deformities (%) | 66 % |
| DAS 28 CRP (mean value) | 3.8 (+/− 1.2) |
| Extra-articulaire manifestations (%) | 64% |
| Positivity of Rheumatoid Factor | 20/30 (66.6%) |
| Positivity of anti-CCP | 29/30 (96.6%) |
| Prednisone | 98% |
| Methotrexate | 70% |
| Sulfasalazine | 28% |
| Hydroxychloroquine | 50% |
| Patients followed by up to 1 DMARD | 34% |